Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Authors
Keywords
-
Journal
Nature Communications
Volume 7, Issue -, Pages 12632
Publisher
Springer Nature
Online
2016-08-30
DOI
10.1038/ncomms12632
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation
- (2016) Chia-Wei Li et al. CANCER RESEARCH
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
- (2014) Diego O. Croci et al. CELL
- Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
- (2013) Jason E. Hudak et al. CHEMISTRY & BIOLOGY
- Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer
- (2013) M. Sznol et al. CLINICAL CANCER RESEARCH
- Programmed death ligand-1 expression in non-small cell lung cancer
- (2013) Vamsidhar Velcheti et al. LABORATORY INVESTIGATION
- EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
- (2013) Jia Shen et al. NATURE
- Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3
- (2013) Vladimir Vigdorovich et al. STRUCTURE
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
- Regulation of Ubiquitination-Mediated Protein Degradation by Survival Kinases in Cancer
- (2012) Hirohito Yamaguchi et al. Frontiers in Oncology
- Mechanisms and principles of N-linked protein glycosylation
- (2011) Flavio Schwarz et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- The Novel Costimulatory Programmed Death Ligand 1/B7.1 Pathway Is Functional in Inhibiting Alloimmune Responses In Vivo
- (2011) J. Yang et al. JOURNAL OF IMMUNOLOGY
- p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs
- (2011) Chun-Ju Chang et al. NATURE CELL BIOLOGY
- Golgi Glycosylation
- (2011) P. Stanley Cold Spring Harbor Perspectives in Biology
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- Epigenetic Changes Induced by Reactive Oxygen Species in Hepatocellular Carcinoma: Methylation of the E-cadherin Promoter
- (2008) Seung-Oe Lim et al. GASTROENTEROLOGY
- ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
- (2008) Jer-Yen Yang et al. NATURE CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started